Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Assess the Pharmacokinetic Profile of Nusinersen (BIIB058) Administered Via the ThecaFlex DRx™ System (PIERRE-PK)

NCT06555419 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT06555419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06555419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Assess the Pharmacokinetic Profile of Nusinersen (BIIB058) Administered Via the ThecaFlex DRx™ System (PIERRE-PK)
Lead sponsor
Biogen
Phase
Phase 1
Overall status
Recruiting
Start date
January 16, 2025
Completion date
September 30, 2027
Enrollment
78 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

muscular atrophy, spinal